Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension

References

• Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 2010;12:135–42
   PubMed Web of Science ®Google Scholar
• Cottone S, Lorito MC, Riccobene R, et al. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 2008;21:175–9
   PubMed Web of Science ®Google Scholar
• Schulz E, Jansen T, Wenzel P, et al. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008;10:1115–26
   PubMed Web of Science ®Google Scholar
• Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008;31:S181–4
   PubMed Web of Science ®Google Scholar
• Sedeek M, Hébert RL, Kennedy CR, et al. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 2009;18:122–7
   PubMed Web of Science ®Google Scholar
• Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71:247–58
   PubMed Web of Science ®Google Scholar
• Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 2005;7:1302–14
   PubMed Web of Science ®Google Scholar
• Puddu P, Puddu GM, Cravero E, et al. The molecular sources of reactive oxygen species in hypertension. Blood Press 2008;17:70–7
   PubMed Web of Science ®Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004;44:248–52
   PubMed Web of Science ®Google Scholar
• Channon KM, Guzik TJ. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 2002;53:515–24
   PubMed Web of Science ®Google Scholar
• Tsuda K. Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: an electron spin resonance investigation. Int Heart J 2010;51:121–4
   PubMed Web of Science ®Google Scholar
• Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 2005;205:1–16
   PubMed Web of Science ®Google Scholar
• Kalous M, Drahota Z. The role of mitochondria in aging. Physiol Res 1996;45:351–9
   PubMed Web of Science ®Google Scholar
• Cazzola R, Rondanelli M, Russo-Volpe S, et al. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 2004;45:1846–51
   PubMed Web of Science ®Google Scholar
• Vajreswari A, Rupalatha M, Rao PS. Effect of altered dietary n-6-to-n-3 fatty acid ratio on erythrocyte lipid composition and membrane-bound enzymes. J Nutr Sci Vitaminol (Tokyo) 2002;48:365–70
   PubMed Web of Science ®Google Scholar
• Kato M, Hayashi R, Tsuda T, Taniguchi K. High pressure-induced changes of biological membrane. Study on the membrane-bound Na(+)/K(+)-ATPase as a model system. Eur J Biochem 2002;269:110–18
   Google Scholar
• Tsuda K, Nishio I. An association between plasma asymmetric dimethylarginine and membrane fluidity of erythrocytes in hypertensive and normotensive men: an electron paramagnetic resonance investigation. Am J Hypertens 2005;18:1243–8
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Bächler JP, Araya J, et al. Relationship between (Na,K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem 2007;303:73–81
   PubMed Web of Science ®Google Scholar
• Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007;20:392–7
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007;21:111–27
   PubMed Web of Science ®Google Scholar
• Schyvens CG, Andrews MC, Tam R, et al. Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats. Clin Exp Hypertens 2007;29:465–78
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Miranda A. Vitamin C: nutritional role, supplementation in pathophysiological states & side effects. New York: Nova Publishers; 2010
   Google Scholar
• Niki E, Noguchi N, Tsuchihashi H, Gotoh N. Interaction among vitamin C, vitamin E, and β-carotene. Am J Clin Nutr 1995;62:1322S–6S
   PubMed Web of Science ®Google Scholar
• May JM, Qu ZC, Mendiratta S. Protection and recycling of α-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 1998;349:281–9
   PubMed Web of Science ®Google Scholar
• Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 2000;87:349–54
   PubMed Web of Science ®Google Scholar
• Ulker S, McKeown P, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534–9
   PubMed Web of Science ®Google Scholar
• Attia DM, Verhagen AM, Stroes ES, et al. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J. Am. Soc. Nephrol 2001;12:2585–93
   PubMed Web of Science ®Google Scholar
• Abdollahzad H, Eghtesadi S, Nourmohammadi I, et al. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int J Vitam Nutr Res 2009;79:281–7
   PubMed Web of Science ®Google Scholar
• Myers MG, Tobe SW, McKay DW, Bolli P. New algorithm for the diagnosis of hypertension. Am J Hypertens 2005;8:1369–74
   Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5–10
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;289:2560–72
   Google Scholar
• Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936–42
   PubMed Web of Science ®Google Scholar
• O'Brien E, Mee F, Atkins N, O'Malley K. Short report: accuracy of the Spacelabs 90207 determined by to the British Hypertension Society Protocol. J Hypertens 1991;9:573–4
   PubMed Web of Science ®Google Scholar
• Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992;20:227–32
   PubMed Web of Science ®Google Scholar
• Sun M, Tien J, Jones R, Ward R. A new approach to reproducibility assessment: clinical evaluation of SpaceLabs Medical oscillometric blood pressure monitor. Biomed Instrum Technol 1996;30:439–48
   PubMedGoogle Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as: a measure of “antioxidant power”: the FRAP assay. Anal Biochem 1996;239:70–6
   PubMed Web of Science ®Google Scholar
• Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214–26
   PubMed Web of Science ®Google Scholar
• Milne GL, Musiek ES, Morrow JD. F(2)-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005;10:10–23
   PubMed Web of Science ®Google Scholar
• Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using AchE as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170–3
   PubMed Web of Science ®Google Scholar
• Chung WY, Chung JK, Szeto YT, et al. Plasma ascorbic acid: measurement, stability and clinical utility revisited. Clin Biochem 2001;34:623–7
   PubMed Web of Science ®Google Scholar
• Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002;17:422–7
   PubMed Web of Science ®Google Scholar
• Katz AI, Epstein FH. The role of sodium-potassium-activated adenosine triphosphatase in the reabsorption of sodium by the kidney. J Clin Invest 1967;46:1999–2011
   PubMed Web of Science ®Google Scholar
• Taussky HH, Shorr E. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 1953;202:675–85
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75
   PubMed Web of Science ®Google Scholar
• Huertas JR, Palomino N, Ochoa JJ, et al. Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns. Biofactors 1998;8:133–7
   PubMed Web of Science ®Google Scholar
• Bligh EG, Dyer WJ. A rapid method of total lipid extraction. Can J Biochem Physiol 1959;37: 911–17
   PubMedGoogle Scholar
• Holman RT, Johnson SB, Kokmen E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 1989;86:4720–4
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Prat H, Passalacqua W, et al. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond) 2008;114:625–34
   PubMed Web of Science ®Google Scholar
• Begg DP, Sinclair AJ, Stahl LA, et al. Hypertension induced by omega-3 polyunsaturated fatty acid deficiency is alleviated by alpha-linolenic acid regardless of dietary source. Hypertens Res 2010;33:808--13
   Google Scholar
• Krug S, Zhang Y, Mori TA, et al. N-Acetylcysteine prevents but does not reverse dexamethasone-induced hypertension. Clin Exp Pharmacol Physiol 2008;35:979–81
   PubMed Web of Science ®Google Scholar
• Herrera EA, Verkerk MM, Derks JB, Giussani DA. Antioxidant treatment alters peripheral vascular dysfunction induced by postnatal glucocorticoid therapy in rats. PLoS One 2010;5:e9250
   PubMed Web of Science ®Google Scholar
• Mori TA, Burke V, Puddey I, et al. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J Hypertens 2009;27:1863–72
   PubMed Web of Science ®Google Scholar
• Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 2009;102:1065–74
   PubMed Web of Science ®Google Scholar
• Begg DP, Sinclair AJ, Stahl LA, et al. Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension. Am J Hypertens 2010;23:125–8. Epublication 5 Nov 2009
   PubMed Web of Science ®Google Scholar
• Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003;41:1096–101
   PubMed Web of Science ®Google Scholar
• Uyuklu M, Meiselman HJ, Baskurt O. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties. Clin Hemorheol Microcirc 2007;36:25–33
   PubMed Web of Science ®Google Scholar
• Tsuda K. Associations between high-sensitivity C-reactive protein and membrane fluidity of red blood cells in hypertensive elderly men: an electron spin resonance study. Int J Hypertens 2012;2012:292803
   PubMedGoogle Scholar
• Uydu HA, Yildirmis S, Orem C, et al. The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia. J Membrane Biol 2012;245:697–705
   PubMed Web of Science ®Google Scholar
• Zamaria N. Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reprod Nutr Dev 2004;44:273–82
   PubMedGoogle Scholar
• Malfatti CR, Burgos LT, Rieger A, et al. Decreased erythrocyte NA+,K+-ATPase activity and increased plasma TBARS in prehypertesive patients. Scientific World Journal 2012;2012:348246
   Google Scholar
• Rodrigo R. Hypertension. In: Rodrigo R, editor. Oxidative stress and antioxidants: their role in human disease. New York: Nova Publishers; 2009b: pp. 25–62
   Google Scholar
• Sládková M, Kojsová S, Jendeková L, Pechánová O. Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats. Physiol Res 2007;56:S85–91
   PubMed Web of Science ®Google Scholar
• Tsuda K, Nishio I, Masuyama Y. The role of sodium-potassium adenosine triphosphatase in the regulation of membrane fluidity of erythrocytes in spontaneously hypertensive rats: an electron paramagnetic resonance investigation. Am J Hypertens 1997;10:1411–14
   PubMed Web of Science ®Google Scholar
• Kocak-Toker N, Giris M, Tulubas F, et al. Peroxynitrite induced decrease in Na+, K+-ATPase activity is restored by taurine. World J Gastroenterol 2005;11:3554–7
   PubMed Web of Science ®Google Scholar
• Rupérez FJ, García-Martínez D, Baena B, et al. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. J Pharm Pharmacol 2008;60:871–8
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Guichard C, Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007;21:111–27
   PubMed Web of Science ®Google Scholar
• Herrera E, Jiménez R, Aruoma OI, et al. Aspects of antioxidant foods and supplements in health and disease. Nutr Rev 2009;67:S140–4
   PubMed Web of Science ®Google Scholar
• Evans ZP, Mandavilli BS, Ellett JD, et al. Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion. Transplant Proc 2009;41:4094–8
   PubMed Web of Science ®Google Scholar
• Evans ZP, Ellett JD, Fariss MW, et al. Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers. Transplant Proc 2008;40:3327–9
   PubMed Web of Science ®Google Scholar
• Berthiaume JM, Oliveira PJ, Fariss MW, Wallace KB. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction. Cardiovasc Toxicol 2005;5:257–67
   PubMed Web of Science ®Google Scholar
• Hathcock JN, Azzi A, Blumberg J, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 2005;81:736–45
   PubMed Web of Science ®Google Scholar
• Roberts LJ 2nd, Traber MG, Frei B. Vitamins E and C in the prevention of cardiovascular disease and cancer in men. Free Radic Biol Med 2009;46:1558
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Prat H, Passalacqua W, et al. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007;30:1159–67
   PubMed Web of Science ®Google Scholar
• Martina V, Masha A, Gigliardi VR, et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008;31:940–4
   PubMed Web of Science ®Google Scholar